Elsevier

The Lancet Neurology

Volume 12, Issue 6, June 2013, Pages 563-571
The Lancet Neurology

Articles
Prediction of seizure likelihood with a long-term, implanted seizure advisory system in patients with drug-resistant epilepsy: a first-in-man study

https://doi.org/10.1016/S1474-4422(13)70075-9Get rights and content

Summary

Background

Seizure prediction would be clinically useful in patients with epilepsy and could improve safety, increase independence, and allow acute treatment. We did a multicentre clinical feasibility study to assess the safety and efficacy of a long-term implanted seizure advisory system designed to predict seizure likelihood and quantify seizures in adults with drug-resistant focal seizures.

Methods

We enrolled patients at three centres in Melbourne, Australia, between March 24, 2010, and June 21, 2011. Eligible patients had between two and 12 disabling partial-onset seizures per month, a lateralised epileptogenic zone, and no history of psychogenic seizures. After devices were surgically implanted, patients entered a data collection phase, during which an algorithm for identification of periods of high, moderate, and low seizure likelihood was established. If the algorithm met performance criteria (ie, sensitivity of high-likelihood warnings greater than 65% and performance better than expected through chance prediction of randomly occurring events), patients then entered an advisory phase and received information about seizure likelihood. The primary endpoint was the number of device-related adverse events at 4 months after implantation. Our secondary endpoints were algorithm performance at the end of the data collection phase, clinical effectiveness (measures of anxiety, depression, seizure severity, and quality of life) 4 months after iniation of the advisory phase, and longer-term adverse events. This trial is registered with ClinicalTrials.gov, number NCT01043406.

Findings

We implanted 15 patients with the advisory system. 11 device-related adverse events were noted within four months of implantation, two of which were serious (device migration, seroma); an additional two serious adverse events occurred during the first year after implantation (device-related infection, device site reaction), but were resolved without further complication. The device met enabling criteria in 11 patients upon completion of the data collection phase, with high likelihood performance estimate sensitivities ranging from 65% to 100%. Three patients' algorithms did not meet performance criteria and one patient required device removal because of an adverse event before sufficient training data were acquired. We detected no significant changes in clinical effectiveness measures between baseline and 4 months after implantation.

Interpretation

This study showed that intracranial electroencephalographic monitoring is feasible in ambulatory patients with drug-resistant epilepsy. If these findings are replicated in larger, longer studies, accurate definition of preictal electrical activity might improve understanding of seizure generation and eventually lead to new management strategies.

Funding

NeuroVista.

Introduction

Epilepsy is a common and serious group of neurological disorders that is characterised by recurrent seizures and affects more than 60 million people worldwide. 30–40% of cases are not adequately controlled with current treatments.1 Resective surgery, though often effective, is either not appropriate or not available for most patients with inadequately controlled epilepsy. Although the morbidity and mortality associated with epilepsy is largely related to the immediate effects of loss of consciousness, such as falls and injury, and the life-threatening risk of status epilepticus, the inherent unpredictability of seizures contributes substantially to the risk of injury, mortality, and psychosocial disability. Quality-of-life impairments associated with epilepsy compare unfavourably with those associated with many other chronic illnesses, such as hypertension, diabetes, and heart disease,2 and the uncertainty of seizure occurrence is a major component of this impairment.3

Although the occurrence of seizures is deemed unpredictable, evidence shows that changes occur in the brain before attacks. This evidence is provided by anecdotal reports of prodromes, which have been described by patients or noted by caregivers and feature subtle changes in behaviour, in the hours or sometimes days before a seizure occurs. Additionally, functional MRI studies4, 5, 6 and near-infrared spectroscopy7, 8 have shown that perfusion increases before seizures. Transcranial magnetic stimulation experiments have shown that the brain is in a hyperexcitable state before seizures.9, 10 Other techniques, including auditory and visual steady-state responses11 and direct electrical stimulation12 of the brain, suggest that cortical hyperexcitability is a precursor to epileptic seizures. These findings suggest that seizures might be anticipated by careful observation of the brain. Reliable anticipation of seizure occurrence could allow patients to avoid dangerous situations and enable administration of treatments, such as electrical stimulation or acute drug delivery, targeted to when a seizure is likely to occur, rather than chronic administration, which is current clinical practice.

The seizure advisory system is a hand-held device that receives and analyses electroencephalography (EEG) signals recorded directly from the surface of the brain, and then provides a visual and audible signal showing the likelihood of a seizure in the minutes or hours ahead. Here we report the results of the first study to assess the safety and efficacy of the seizure advisory system in patients with drug-resistant epilepsy.

Section snippets

Study design and participants

Before our study, NeuroVista (Seattle, WA, USA) assembled a large database of scalp and intracranial electroencephalograms (EEGs) recorded during assessments of epilepsy-monitoring units at several academic centres. A development and validation test library of intracranial subdural grid EEG recordings from 49 patients (total duration 7192 h) was derived from these data.

A purpose-built cluster-computing environment was developed to assist in the search for a suitable algorithm on the basis of

Results

We enrolled 17 patients, two of whom dropped out before engaging in the study and are not included in further results. Nine men and six women (mean age 44·5 years [SD 13·0, range 20–62]) were implanted with the device. Six patients had undergone previous epilepsy resection, and one had used vagus nerve stimulation, which was explanted when the seizure advisory system was implanted (table 1).

Clinical effectiveness data are not available for 12 months after implantation because variability in

Discussion

Our study is the first to record long-term EEGs in an ambulatory setting in human beings and to show successful prospective seizure prediction. Implantation of the seizure advisory system was generally well tolerated, and the device met expectations about data acquisition and analysis, although improvements in the transmission quality from the implantable telemetry unit would be beneficial (panel).

Our study had some limitations. Patients had heterogeneous focal epilepsies, and all had

References (38)

  • F Mormann et al.

    On the predictability of epileptic seizures

    Clin Neurophysiol

    (2005)
  • H Stefan et al.

    Objective quantification of seizure frequency and treatment success via long-term outpatient video-EEG monitoring: a feasibility study

    Seizure

    (2011)
  • P Kwan et al.

    Early identification of refractory epilepsy

    N Engl J Med

    (2000)
  • BG Vickrey et al.

    Quality of life of epilepsy surgery patients as compared with outpatients with hypertension, diabetes, heart disease, and/or depressive symptoms

    Epilepsia

    (1994)
  • M Zhao et al.

    Focal increases in perfusion and decreases in hemoglobin oxygenation precede seizure onset in spontaneous human epilepsy

    Epilepsia

    (2007)
  • P Federico et al.

    Functional MRI of the pre-ictal state

    Brain

    (2005)
  • PD Adelson et al.

    Noninvasive continuous monitoring of cerebral oxygenation periictally using near-infrared spectroscopy: a preliminary report

    Epilepsia

    (1999)
  • E Slone et al.

    Near-infrared spectroscopy shows preictal haemodynamic changes in temporal lobe epilepsy

    Epileptic Disord

    (2012)
  • M-ASY Wright et al.

    Cortical excitability predicts seizures in acutely drug-reduced temporal lobe epilepsy patients

    Neurology

    (2006)
  • Cited by (0)

    View full text